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Abstract—For many macromolecular systems the accurate
sampling of the relevant regions on the potential energy surface
cannot be obtained by a single, long Molecular Dynamics
(MD) trajectory. New approaches are required to promote more
efficient sampling. We present the design and implementation of
the Extensible Toolkit for Advanced Sampling and analYsis (Ex-
TASY) for building and executing advanced sampling workflows
on HPC systems. ExTASY provides Python based “templated
scripts” that interface to an interoperable and high-performance
pilot-based run time system, which abstracts the complexity of
managing multiple simulations. ExTASY supports the use of
existing highly-optimised parallel MD code and their coupling
to analysis tools based upon collective coordinates which do not
require a priori knowledge of the system to bias. We describe
two workflows which both couple large “ensembles” of relatively
short MD simulations with analysis tools to automatically analyse
the generated trajectories and identify molecular conformational
structures that will be used on-the-fly as new starting points for
further “simulation-analysis” iterations. One of the workflows
leverages the Locally Scaled Diffusion Maps technique; the other
makes use of Complementary Coordinates techniques to enhance
sampling and generate start-points for the next generation of MD
simulations. We show that the ExTASY tools have been deployed
on a range of HPC systems including ARCHER (Cray CX30),
Blue Waters (Cray XE6/XK7), and Stampede (Linux cluster),
and that good strong scaling can be obtained up to 1000s of
MD simulations, independent of the size of each simulation. We
discuss how ExTASY can be easily extended or modified by end-
users to build their own workflows, and ongoing work to improve
the usability and robustness of ExTASY.
I. INTRODUCTION AND MOTIVATION
Approximately 30-40% of compute cycles on US
XSEDE [1], [2] is devoted to research on biomolecular sys-
tems using Molecular Dynamics (MD) simulations. Much of
the computational cost comes from the need for an adequate
sampling of the conformational space accessible to these
complex and flexible systems in order to answer a particular
research question. For example, to calculate free energies
one needs an adequate sample from the Boltzmann weighted
ensemble of states for the system in order to estimate the
thermodynamic quantity of interest. Another example is the
study of kinetic processes such as self-assembly or drug-target
association, where the integration of data from large numbers
of trajectories is required to build a statistically meaningful
model of the dynamical process.
The high dimensionality of these macromolecular systems
and the complexity of the associated potential energy surfaces
(creating multiple metastable regions connected by high free
energy barriers) pose significant challenges to adequately sam-
ple the relevant regions of the configurational space. In other
words, beside the “curse of dimensionality” associated with the
large number of degrees of freedom, MD trajectories can easily
get “trapped” in a low free energy state and fail to explore
other biologically relevant states. The waiting time to escape
from a local free energy minimum increases exponentially
with the height of the free energy barrier that needs to be
crossed to reach another state. Metastable states separated by
free energy barriers of several tens of kBT (where kB is the
Boltzmann constant and T is the physiological temperature)
are not uncommon in biologically relevant systems, but can not
at present be routinely sampled with standard MD simulations.
In practice, better sampling of the relevant regions of a
macromolecule configurational space can be achieved through
methodologies able to bias the sampling towards scarcely
visited regions, reducing the waiting time inside a metastable
state by artificially flattening the energy barriers between
states - e.g. Metadynamics [3] or Accelerated Dynamics [4].
Although the results can be usually reweighed to reproduce
the correct Boltzmann statistics, kinetics properties are not
easily recovered from biased simulations (unless used in
combinations with unbiased simulations, see e.g. [5]). In
addition, the design of an effective bias usually requires some
a priori information on the system of interest, for instance
on a suitable choice of collective variables to describe slow
timescale processes.
An alternative approach to tackle the sampling problem is
the development of ensemble or swarm simulation strategies,
where data from large numbers of simulations, which may
be weakly coupled or not coupled at all, are integrated (e.g.
Replica Exchange [6] and Markov State Models (MSMs) [7]).
This last class of methods is of increasing interest for
a variety of reasons. Firstly, the hardware roadmap is now
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based almost entirely on increasing core counts, rather than
clock speeds. On the face of it, these developments favour
weak scaling problems (larger and larger molecular systems
to be simulated) over strong scaling problems (getting more
data faster on a system of fixed size). However, by running
ensembles of simulations over these cores and integrating the
data using, e.g. MSM approaches, timescales far in excess
of those sampled by any individual simulation are effectively
accessed. In the last few years several studies have been
published [8]–[12] where, using MSM methods, processes
such as protein folding or ligand binding have been completely
and quantitatively characterized (thermodynamically and ki-
netically) from simulations orders of magnitude shorter than
the process of interest.
It is becoming increasingly clear that the application of
ensemble simulation strategies on state-of-the-art computa-
tional facilities has an unparalleled potential to permit accurate
simulations of the largest, most challenging, and generally
most biologically relevant, biomolecular systems. The main
challenge in the development of the ensemble approach for
faster sampling of complex macromolecular systems is on
the design of strategies to adaptively distribute the trajecto-
ries over the relevant regions of the systems configurational
space, without using any a priori information on the system
global properties. The definition of smart “adaptive sampling”
approaches that can redirect computational resources towards
unexplored yet relevant regions is currently of great interest.
In light of the challenge posed by trends in computer
architecture, the need to improve sampling, and the range of
existing MD codes and analysis tools, we have designed and
implemented the Extensible Toolkit for Advanced Sampling
and analYsis (ExTASY). ExTASY provides three key features
within a single framework to enable the development and
applications requiring advanced sampling in a flexible and
highly scalable environment. Firstly, as an extensible toolkit,
ExTASY allows a wide range of existing software to be
integrated, leveraging the significant community investment
in highly optimised and well-tested software packages and
enabling users to continue to work with tools that they are
familiar with. Support for specific MD codes and analysis
tools is provided in order to demonstrate how ExTASY may
be used, but users can easily add other tools as needed.
Secondly, ExTASY is flexible, providing a programmable
interface to link individual software components together and
construct sampling workflows. Workflows capture a sequence
of execution of individual tools, and the data transfers and
dependencies between them. First class support is provided
for defining large ensembles of independent simulations. Thus
complex calculations may be scripted and then executed
without the need for user intervention.
Thirdly, ExTASY workflows may be executed either locally,
or on remote High Performance Computing systems. Com-
plexities such as the batch queueing system and data transfer
are abstracted, making it easy for users to make use of the
most appropriate compute resources they have access to. In
addition, this abstraction allows workflows to be executed
without exposing each component to queue waiting time, and
respecting the dependencies defined in the workflow, for many
simulations to be scheduled and executed in parallel.
The rest of the paper is organized as follows: In the next
section we discuss the design and implementation of ExTASY.
After a brief discussion in Section III of two distinct appli-
cations that have been used to design and validate ExTASY,
Section IV provides a careful analysis of the performance and
scalability of ExTASY. Given the complex interplay between
functionality and performance when designing an extensible
and production tool, we perform a wide range of experiments
aimed to investigate strong and weak scaling properties, inter
alia over a set of heterogeneous HPC platforms. We conclude
with a discussion of the scientific impact as well as the lessons
for sustainable software development.
II. RELATED WORK
The need for better sampling has driven developments
in methodology (algorithm), hardware, and software for
(bio)molecular simulation.
One of the features of the popular Metadynamics method
[3] or Accelerated Dynamics [4] is that a constant analysis of
what has been sampled so far is used to bias future sampling
into unexplored regions. A range of alternative approaches are
now emerging that do likewise, but where alternating segments
of data-gathering, and analysis to inform the direction of future
sampling, are more coarsely grained. This iterative approach
has the advantage over the metadynamics method that the
identity of “interesting” directions for enhanced sampling does
not need to be defined a priori, but can emerge and respond
flexibly to the developing ensemble. Another advantage is that
the MD-based sampling process and analysis method do not
have to be implemented within the same executable, or in
two tightly-coupled executables, permitting greater flexibility.
Many such methods make use of collective variables (CVs)
to define directions in which to promote sampling. A variety
of novel, and established, algorithms for the unsupervised
and adaptive construction of CVs exist. In addition to the
work of Preto and Clementi [13], interleaving cycles of MD
simulation with data analysis through Locally Scaled Diffusion
Maps [14], related methods include the non-targeted PaCS-
MD method of Harada and Kitao [15], variants thereof [16],
and the PCA-based method of Peng and Zhang [17].
Better sampling can also come from faster sampling, which
has been enabled through hardware developments such as
ANTON [18] and MD-GRAPE [19]. These special purpose
computers enable much faster calculations of the different
contributions to the forces along the trajectories, thus speeding
up the clock time required to perform a time integration
step in the MD simulation and allowing execution of sig-
nificantly longer MD trajectories. The cost of, and access
to such special purpose computers ensure that in spite of
their potential, they will not be as accessible for the wider
scientific community as general purpose approaches. Further
ANTON requires a customized ecosystem, from bespoke MD
engines and ANTON specific data analysis middleware (e.g.,
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HiMach). Thus ANTON style special-purpose approaches to
bio-molecular simulation science cannot take advantage of the
rich community driven advances and eco-system.
Methods such as Replica Exchange and Metadynamics
require a tight coupling between the simulation and analysis
processes, and are thus typically implemented as additional
facilities within the core MD code (e.g. replica exchange
methods are implemented in AMBER [20], CHARMM [21],
GROMACS [22], LAMMPS [23], and NAMD [24], for ex-
ample), or are provided by a separate package that com-
municates in a fine-grained manner with the running MD
executable, generally though specially-installed “hooks”; an
example of this approach is the PLUMED package [25]
which provides metadynamics capabilities (amongst others) to
AMBER, GROMACS, LAMMPS, NAMD and also Quantum
ESPRESSO [26]. In contrast, there is, to our knowledge, so far
no established and generally available package to support the
types of coarser-grained, adaptive workflows described above.
III. EXTASY: REQUIREMENTS, DESIGN AND
IMPLEMENTATION
In this section we first present the requirements that have
been considered in the design and implementation of ExTASY,
which we then go on to discuss.
A. Requirements
Consistent with the design of many new software systems
and tools, we analyze the functionality, performance and
usability requirements of ExTASY.
1) Functionality: Specific to sampling, there is a need to
couple two very distinct computational stages; each stage can
be short-lived when compared to the typical duration of mono-
lithic simulation. Furthermore, the two stages differ in their
resource requirements significantly: one stage is characterized
by multiple compute intensive MD simulations, the other by a
single analysis program that operates on data aggregated from
multiple simulations. The “Ex” in ExTASY is a reference to
the extensible nature of the framework, and thus any coupling
must be between the abstraction of stages and not specific
codes for fixed time duration.
Scientists may have access to multiple systems, and wish
to submit jobs on each, or may be forced to migrate from
using one system to another due to CPU time allocation, or
system end-of-life. It is imperative that any software system
support interoperability, i.e. use of heterogeneous systems
with minimal changes. MD simulations may be executed
over multiple nodes, depending on the system size, thus any
software system should also support the ability to execute
tasks over multiple nodes.
2) Performance: In order to obtain good sampling, a large
number of simulations must be executed. In many cases, the
aggregate number of cores required by the set of simulations
(“ensemble”) is much higher than the total number of cores
that are available at a given instance or that can be allocated
on a system. The framework must decouple the aggregate (or
peak) resource requirement of the workload from the number
of cores available or utilized. On the other hand, if access to
a large number of cores is available, the framework should be
able to use them effectively. In this regard, the strong and
weak scalability of the framework is to be investigated.
3) Usability: Depending on the application, the user might
need to change to using a larger/smaller set of input data,
modify simulation parameters or replace any of the simulation
or analysis tools. The framework should offer easy application
setup, minimizing the user’s time and effort in the process.
The user should only be concerned with decisions on “what”
the workflow is and “where” it is being executed. The details
as to “how” the deployment and execution occurs should
be hidden by the underlying software. Thus the framework
should use tools that abstract complexities of deployment
and execution from the user. Workflow users and developers
should be able to concentrate their efforts on the application
logic and expect the underlying software to provide a level of
transparent and automation of aspects such as data movement
and job submission.
B. Design
From these requirements, we identify the following as the
primary design objectives of ExTASY.
1) Support range of HPC systems, abstract task execution,
data movement from the user.
2) Flexible resource management and coupling capabilities
between different stages as well as within a stage.
3) Provide the users with an easy method to specify or
change workload parameters without delving into the
application itself.
These design objectives put together lead to the following
simple software architecture:
1) Middleware for resource and execution management:
The ExTASY framework is aimed to provide an easy method
to run advanced sampling algorithms on HPC systems. In this
process, the ExTASY framework should abstract users from
the complexity of application composition, workload execution
and resource management. There is need for a middleware
that provides such resource and execution management that
provides many of the required functionalities and performance.
The details of how tasks are mapped or executed on to
resources is abstracted from the ExTASY user. The user is
only required to provide details of the workload and identify
the resource(s) that are accessible. This design choice thus ac-
knowledges the separation of concerns: workload description
from its execution on HPC systems.
2) Configuration files: Composing the advanced sampling
algorithms discussed in the previous sections using the com-
ponents provided by a particular middleware stack, requires
specific knowledge of the middleware itself. The ExTASY
framework bypasses this complexity by adding one more level
of abstraction. It provides ready-to-use scripts in accordance
with advanced sampling methods discussed in this paper that
are configurable via configuration files. In these configuration
files, the user is exposed to only application-level, meaningful
parameters that can be modified as necessary.
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Fig. 1. Design of the ExTASY framework using Ensemble Toolkit as
middleware. The ExTASY framework provides ready-to-use scripts created
using components provided by Ensemble Toolkit. Parameters related to the
resource and workload are exposed via configuration files, which alone are
the files that users interact with. Within Ensemble Toolkit, the workload is
converted into executable units by the execution plugins and submitted to the
resource using RADICAL-Pilot.
C. Implementation
1) Ensemble Toolkit: As mentioned previously, ExTASY
requires a middleware for resource and execution management.
We chose to use Ensemble Toolkit [27] as the middleware
component as it provides several relevant features such as the
ability to support MPI tasks, dynamic resource management
– one type of which is to be able to execute more tasks
than the resources available, support for heterogeneous HPC
systems and strong and weak scalability guarantees. Ensemble
Toolkit has been tested upto O(1,000) tasks with short and long
term plans to support O(10,000) and O(100,000) tasks [27].
Ensemble Toolkit is in turn based upon the pilot abstraction
(and the RADICAL-Pilot [28] implementation of the pilot
abstraction) to provide much of the flexible and scalable
resource management capabilities.
Ensemble Toolkit exposes three components to the user that
can be used to express many applications: Kernel Plugins,
Execution Patterns, and Resource Handle. Scripts that are part
of ExTASY framework use these components to describe the
application logic.
2) Configuration files: The application logic is expressed
via components of Ensemble Toolkit. The resource and the
workload specifications are exposed via configuration files.
The ExTASY framework has two types of configuration files:
(i) resource configuration, which consist of details of the
resource where the application will to be executed such as the
resource name, the runtime, and the username and account de-
tails used to access the resource, and (ii) kernel configuration,
which defines the workload parameters such as the location of
input files for the Molecular Dynamcis simulation and analysis
tools, parameters for the tools, and workflow parameters such
as the number of simulations.
Fig. 2. The SAL pattern common to both sampling algorithms. The crux of
the pattern is an iteration over 2 stages: simulation and analysis, where the
number of simulation and analysis instances can be different. The pattern may
also contain pre- and post- processing stages.
IV. APPLICATIONS
We illustrate the capabilities of the ExTASY approach via
two exemplar applications. The two different advanced sam-
pling algorithms implemented with ExTASY are the Diffusion
Map-directed-MD (DM-d-MD) and CoCo-MD techniques.
Both these algorithms have a common execution pattern: an
ensemble of simulation tasks followed by an analysis stage,
performed for multiple iterations following the pattern shown
in Figure 2.
In the case of the DM-d-MD algorithm, the simulation
stage consists of Gromacs and LSDMap in the analysis stage.
Whereas, in the CoCo algorithm, the simulation stage consists
Gromacs runs and trajectory conversions and analysis consists
of CoCo. The individual simulation or analysis tools might
differ depending on the algorithm chosen but the overall
pattern is observed to be the same.
A. Diffusion Map-directed-MD
The Diffusion Map-directed-MD (DM-d-MD) technique
[13] improves the efficiency of computational resources by
choosing which replicas of the protein are used to run MD.
When replicas are too close to each other, the MD trajectories
will be similar. The information gain from simulating MD
with close replicas is small. Part of the replicas which are too
close to each other are deleted. To hold the total number of
replicas constant, replicas which are too far apart from each
other are duplicated. In DM-d-MD, a non-linear dimension-
ality reduction technique, the locally scaled diffusion map
(LSDMap) [14] is used to calculate the distance between
different replicas. The deletion or duplication of replicas would
destroy the correct sampling of the protein. By changing the
weights of individual replicas in the reweighting step, the
correct sampling of the protein is obtained.
The DM-d-MD technique requires only the protein starting
structure. No additional information about the protein is nec-
essary. The user can fine tune the sampling mainly by varying
the total number of replicas and the way how the local scale
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in LSDMap is calculated. At the begin on the method, the
replicas are generated from the protein starting structure. After
the MD step, the LSDMap is calculated. LSDMap requires
only the final structure for each replica from the MD step.
Based on the LSDMap results new replicas for the next
iteration of DM-d-MD are chosen from the current replicas.
The reweighting ensures that the
It was shown that DM-d-MD technique is, at least, one
order of magnitude faster compared to plain MD [13]. This
comparison was done for alanine dipeptide and a 12-aminoacid
model system, Ala12.
B. The CoCo-MD workflow
The CoCo (Complementary Coordinates) technique [29]
was designed originally as a method to enhance the diversity
of ensembles of molecular structures of the type produced by
NMR structure determination. The method involves the use of
PCA [30]–[32] in Cartesian space to map the distribution of
the ensemble in a low (typically 2-4 dimensional) space, and
then the identification of un-sampled regions. CoCo generates
new conformations for the molecule that would correspond
to these un-sampled regions. The number of new structures
generated is under the users control the algorithm divides the
space into bins at a chosen resolution, marks bins as sampled
or not, first returns a structure corresponding to the centre of
the un-sampled bin furthest from any sampled one, marks this
bin as now sampled, and iterates as many times as desired.
In the CoCo-MD workflow, an ensemble of structures from
MD simulations are analysed using the CoCo method; new
conformations become the start points for a new round of
MD simulations. The latest MD data is added to the previous
set, and CoCo repeated. The method is agglomerative - all
MD data generated so far is used for each analysis; but also
adaptive - a fresh PCA is performed each time. Applied
to simulations of the alanine pentapeptide, the CoCo-MD
workflow is able to reduce mean first passage times from the
extended state to other local minimum states by factors of ten
or greater compared to conventional simulations [33].
V. PERFORMANCE EVALUATION
A. Experiment setup
1) Physical system: The 39-residue mixed α/β protein
NTL9(1-39) (pdb code 2HBA, 14,100 atoms including water)
is chosen as the physical system for our experiments. NTL9
has an experimentally measured folding time of around 1.5
ms [34], and its folding process has been extensively studied
by experiment and all-atom MD simulations, both by means
of the Folding@Home distributed computing platform coupled
with MSM analysis [9], and by Anton supercomputer [35].
The relatively small size of NTL9, and the existence of
previous MD simulation results over long timescales, make
this protein an ideal candidate for testing and benchmarking
our approach. Albeit small, NTL9 is much larger than a simple
peptide, and exhibits a folding process with two competing
routes [35], thus presenting a non-trivial test for adaptive
sampling.
2) HPC systems used: One of the requirements of ExTASY
as that it should be interoperable, so we have used several
different HPC systems for our experiments, and characterised
the performance of ExTASY on each.
Stampede is a Dell Linux cluster located at the Texas
Advanced Computing Center, and is part of the Extreme
Science and Engineering Discovery Environment (XSEDE).
It consists of 6400 compute nodes, each with 2 Intel Xeon
‘Sandy Bridge’ processors, for a total of 16 CPU cores per
node, as well as an Intel Xeon Phi co-processor (not used in
our experiments). Stampede uses the SLURM batch scheduler
for job submission.
ARCHER is a Cray XC30 supercomputer hosted by EPCC,
and operated on behalf of the Engineering and Physical Sci-
ences Research Council (EPSRC) and the Natural Enviroment
Research Council (NERC). It has 4920 compute nodes, each
with 2 Intel Xeon ‘Ivy Bridge’ processors, giving 24 cores per
node. ARCHER uses the Portable Batch System (PBS) for job
submission.
Blue Waters is a Cray XE6/XK7 operated by the National
Centre for Supercomputing Applications on behalf of the
National Science Foundation and the University of Illinois.
The XE6 partition used in this work consists of 22640 compute
nodes with 2 AMD ‘Interlagos’ processors, giving 32 cores
per node. Blue Waters uses the TORQUE/Moab workload
manager for job submission.
B. Evaluation of individual components
Since the performance of the entire workflow depends on the
performance of each of the component parts, we investigate the
scaling of both the simulation code (Gromacs) and the analysis
tools in isolation on each of the three target platforms, using
the NTL9 system used for the full sampling workflows.
1) Simulation tools: The parallel efficiency of Gromacs
with respect to a single core on each machine is shown in
Figure 3. While efficincies of 69% (ARCHER, 24 cores), 78%
(Stampede, 16 cores) and 46% (Blue Waters, 32 cores) suggest
that while the scaling for such a relatively small simulation
is not ideal, using a single node per simulation is a good
use of the available hardware. Beyond a single node, the
efficiency drops off so although multiple node simulation tasks
are supported by Ensemble Toolkit they are not useful for this
benchmark case.
2) Analysis tools: Due to the nature of the two workflows,
there are many parallel simulation tasks, but only a single
analysis task. Therefore, the analysis task may be configured to
run on as many cores as are available to the simulations. Both
CoCo and LSDMap are parallelised using MPI, and consist of
parts which are independent, e.g., reading of trajectory files
in CoCo, and involve communication e.g. diagonalisation of
the covariance matrix in CoCo and the diffusion matrix in
LSDMap, so the parallel scaling is expected to be sub-linear.
The performance of CoCo is also strongly dependent on I/O
since it reads the entire trajectory file rather than just the final
configurations like LSDMap.
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Fig. 3. Gromacs parallel efficiency on ARCHER, Blue Waters and Stampede.
A single 20ps gromacs simulation of the NTL9 system is performed using
various core counts on the three machines and the execution time is measured.
Fig. 4. Strong scaling of CoCo analysis tool on ARCHER, Blue Waters and
Stampede. A total of 256 simulations are analyzed using various core counts
on the three machines and execution time is measured.
Fig. 5. Parallel efficiency of LSDMap on ARCHER, Blue Waters and
Stampede. A total of 2449 structures are analyzed using various core counts
on the three machines and execution time is measured.
Figures 4 show the strong scaling of CoCo for a fixed input
of 256 simulations. We see that CoCo is able to scale to at
least 256 cores on ARCHER and Blue Waters, and to around
32 cores on Stampede, thus for our following experiments
we configure the workflow to run CoCo with as many cores
as there are input trajectories. LSDMap (Figure 5) however,
does not scale efficiently much beyond a single node on each
machine, even with over 2000 input structures. Nevertheless,
we run LSDMap on as many cores as are available, even
though it cannot use them fully. Due to the structure of the
workflow, those cores would otherwise sit idle during the
analysis phase.
C. Evaluation of ExTASY
Fig. 6. Measurement of overhead from ExTASY on ARCHER, Blue Waters
and Stampede. Using only the simulation stage of the SAL pattern, overhead
from ExTASY is measured on the three machines at various core counts.
1) Characterization of overheads: In addition to the neces-
sity of characterizing performance overhead introduced by a
new system approach and implementation, in order to instill
confidence in potential users of ExTASY it is important to
measure the overheads imposed by ExTASY. The objective
is to discern the contributions from the different aspects of
the ExTASY framework as opposed to MD and analysis
components. The time taken to create, launch and terminate
all of the simulations or the instantiate ExTASY framework
itself on the resource are examples of the former overhead.
All of the experiments use Ensemble Toolkit version 0.3.14.
We ran a single iteration of the workflow with null work-
loads, i.e., where the task did no work (/bin/sleep 0),
but otherwise was configured as a “normal” simulation task,
launched using MPI and taking a whole node on each of
the machines. The number of tasks ranged from 16 to 128,
and they were all run concurrently. Figure 6 shows that
the overheads on Stampede and Blue Waters are relatively
small, growing from <5s to around 15s for 128 tasks. On
ARCHER the overheads are much larger (70-350s), which
after further investigation is due to the aprun job launcher,
which performs poorly when multiple concurrent tasks are
launched.
2) Strong scaling test: To test the strong scaling of the
ExTASY workflows, we fix the number of executing instances
(independent MD simulations) to 128 and vary the total
number of CPU cores used to execute the workflow. The
largest experiments use enough CPU cores that all of the MD
simulations execute concurrently. For example, on ARCHER,
128 instances, each executing on a single node (24 cores) gives
a maximum of 3072 cores.
Since the MD simulations are independent and may be
executed concurrently by ExTASY, we expect that as the
number of cores is increased, the simulation time should
decrease proportionally. The time spent in the analysis part
is expected to be constant since the total amount of MD data
is constant, and despite the parallelisation of the analysis tools
as can be seen from Figure 5, the time to completion plateaus
at fairly low core counts.
Figure 7 (bottom) shows the results of this experiment
for the DM-d-MD workflow executed on Blue Waters. The
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Fig. 7. Strong scaling of DM-d-MD workflow on ARCHER (top) and Blue
Waters (bottom). The number of simulations is held constant at 128, number
of cores per simulation at 24 on ARCHER and 32 on Bluewaters. The total
number of cores used is varied with a constant workload, hence measuring
strong scaling performance of the framework.
simulation time decreases from 395.7s on 512 cores to 79.52s
on 4096 cores, a speedup of 4.97x with 8x as many cores
– yielding a scaling efficiency of 62%. The analysis time is
essentially constant at around 100s, as expected. The loss
of scaling efficiency for the simulation part comes from
two sources. Firstly, there is the fixed overhead discussed in
Section V-C1 associated with the execution of 128 concur-
rent tasks, which is approximately 15s. Secondly, the actual
computation which occurs within each task take longer when
more simulations are run concurrently, due to the fact that
they all write to the same shared filesystem. For example,
when 16 instances are run concurrently on 512 cores, the
MD simulations take an average of 45.6s each. When all 128
instances are run concurrently, each takes 49.0s, or 3.4s slower.
If these effects are removed, the effective scaling efficiency on
4096 cores rises to 77%.
Similar results are obtained on ARCHER (Figure 7, top),
although the scaling of the simulation part tails off on 3072
cores, and the LSDMap analysis takes somewhat longer, with
higher variability than Blue Waters. Both of these are due to
the fact that both the MD and analysis involve significant I/O,
and it is known that opening many small files concurrently is
slow as the metadata servers of the parallel Lustre filesystem
become a bottleneck [36].
CoCo-MD on Stampede (Figure 8, bottom) has similar
strong scaling for the simulation part as DM-d-MD. The
simulation time decreases from 363s on 256 cores to 83.7s
on 2048 cores – a speedup of 4.3x for a 8-fold increase in the
number of cores (54% efficiency). However, the analysis time
(CoCo) does not scale due to the fact that the parallelisation
in CoCo is limited to the number of input trajectories, which
is 128 in this case, even if more cores are available.
The CoCo-MD workflow on ARCHER (Figure8, top) does
not show as good scaling as DM-d-MD, or CoCo-MD on
Fig. 8. Strong scaling of CoCo-MD workflow on ARCHER (top) and
Stampede (bottom). The number of simulations is held constant at 128,
number of cores per simulation at 24 on ARCHER and 16 on Stampede.
The total number of cores used is varied with a constant workload, hence
measuring strong scale performance of the framework.
the other platforms. The reason for this lies in the fact that
after the actual molecular dynamics calculation, a ‘trajectory
conversion’ step is required to prepare the data for CoCo.
This step only takes a fraction of a second to execute, but
there is a very large overhead caused by aprun, which
allocates resources to and launches each individual task. This
does not occur on Blue Waters, which uses the ORTE [37]
implementation of RADICAL-Pilot that is not yet default on
ARCHER.
3) Weak scaling test: To investigate the weak scaling prop-
erties of ExTASY, we fix the ratio of number of instances
to CPU cores, and vary the number of instances with the
constraint that all simulations can execute concurrently. For
example, on ARCHER 16 instances are executed on one node
each (24 cores) giving a total of 384 cores, and the number
of instances is increased to 128, i.e., the number of cores is
3072.
Since all simulations run concurrently, and the length of
each simulation does not change, we expect the simulation
time to be a constant. However, the analysis part will increase
since the performance of the analysis tools is a function both
of the input data size (depending on the number of instances),
as well as the number of cores available, and even though the
number of cores is proportional to the data size, the amount
of work grows faster than linearly with the data size.
For the DM-d-MD workflow on Blue Waters (Figure 9, top)
we observe a small increase of 21.8s in the simulation part as
we scale from 512 to 4096 cores. Similar to the strong scaling
results, this is combination of the overhead due to the increased
number of tasks with a slowdown of the individual tasks
themselves. The analysis is found to increase sub-linearly. As
discussed in section V-B2 the LSDMap computation consists
of parts which are both linear and quadratic in the size of
the input data. Combined with an increasing number of cores
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Fig. 9. Weak scaling of DM-d-MD workflow on Blue Waters (top) and
Stampede (bottom). The number of cores per simulation is held constant at
32 on Blue Waters and 16 on Stampede. The total number of simulations
is varied from 16-128 and the cores used are increased proportionally. By
keeping the ratio of the workload to the number of resources constant, we
observe the weak scaling performance of the framework.
available for the tool, sub-linear scaling is the result. Simi-
lar behaviour is observed on Stampede (Figure 9, bottom),
although with a different weighting of the simulation and
analysis part, reflecting the fact that the performance of each
kernel depends on how well optimised the application binary
is on the execution platform.
The weak-scaling of CoCo-MD on ARCHER (Figure 10,
top) shows very clearly the aprun bottleneck discussion in
Section V-C2, and the effect increases as the number of con-
current tasks grows. However, the analysis part scales better
than linearly, which is to be expected since CoCo consists
of parts which weak scale ideally (independent operations
per trajectory file) and parts such as the construction and
diagonalisation of the covariance matrix which grow as the
data size squared or more.
On Stampede, the weak scaling of the simulation part of
the CoCo-MD workflow (Figure 10, bottom) is much better
than ARCHER. The simulation time grows only by around 50s
compared to over 700s on ARCHER over the range of cores
that we tested. CoCo scales almost identically to ARCHER.
4) Effect of larger ensembles: To distinguish the effects
caused by strong scaling (increasing parallelism with a fixed
amount of work) and weak scaling (increasing parallelism
proportionally to the amount of work), we also measured the
effect of increasing the amount of work with a fixed number
of compute cores available. Figure 11 shows the results for
the DM-d-MD workflow running on Blue Waters as we vary
the number of MD instances from 128 to 1024, keeping the
total number of cores available at 4096. Since each task runs
on a single node (32 cores per instance), only 128 simulation
tasks can run concurrently. Ideally, we would expect that the
simulation time should increase linearly with the number of
instances. In practice, we see that the time taken grows by
Fig. 10. Weak scaling of CoCo-MD workflow on ARCHER (top) and
Stampede (bottom). The number of cores per simulation is held constant at
24 on ARCHER and 16 on Stampede. The total number of instances is varied
from 16-128 and the cores used are increased proportionally. By keeping the
ratio of the workload to the number of resources constant, we observe the
weak scaling performance of the framework.
Fig. 11. DM-d-MD workflow on Stampede. Workload is increased from 128
instances to 1024, keeping the number of cores constant at 4096. Within the
overheads, the increase in execution time is in proportion with increase in the
workload.
only 7.4x as the number of instances increases from 128 and
1024 i.e., a factor of 8. This is due to the fact that some of the
overheads related to managing the tasks that occur before or
after execution in the 128 task case are one-time overheads,
i.e., those overheads are hidden as they are done concurrently
(in the RADICAL-Pilot Agent) with the execution of the
remaining tasks when the number of instances is greater than
128. The scaling of the analysis part is consistent with that
discussed in Section V-B2, that there is a close to linear scaling
since the larger the ensemble size, the more parallelism is
available in LSDMap
5) Dynamic simulations: An important characteristic of the
LSDMap and CoCo based workflows is that the number of
instances typically changes after each simulation-analysis iter-
ation. Thanks to the pilot-abstraction, the ExTASY framework
supports flexible mapping between the number of concurrent
instances and the total number of cores, while being agnostic
of the number of cores per instance. This functionality is used
by the DM-d-MD workflow, where, depending on the progress
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Fig. 12. Support for dynamic workload in ExTASY: The DM-d-MD algorithm
dictates the number of instances at every iteration. The number of instances
in each iteration (for a total of 5 iterations) when starting with 32, 64, 128
instances is presented.
through the conformation space of the system being explored,
LSDMap may decide to spawn more (or less) trajectories
for the next iteration of sampling. Figure 12 illustrates this
capability. We ran the DM-d-MD workflow on Blue Waters
for three configurations with 32, 64 and 128 initial instances.
We can see that after an initial growth phase the number
of instances seems to stablise for the remaining iterations,
although the difference from the starting configuration and the
number of iterations taken to stabilise is not algorithmically
or systematically predictable. The flexible resource utilization
capabilities that ExTASY is built upon prove critical.
D. Summary of Experiments
We have shown illustrative performance data for two dif-
ferent applications – CoCo-MD and DM-d-MD – based on
different analysis methods, on three distinct HPC platforms
- ARCHER, Blue Waters and Stampede. The overall scaling
to O(1000) simulations is clearly demonstated, and we have
analysed the scaling behaviour of the ExTASY framework
itself (overheads) and the individual simulation and analysis
programs which constitute the workflow.
VI. DISCUSSION AND CONCLUSION
State-of the-art computational biophysics approaches aim
to balance three different requirements: force-fields accu-
racy, advanced sampling capabilities, and rigorous and fast
data analysis. These points are strongly interconnected. In
particular, it is becoming clear that advanced sampling and
data analysis need to be tightly coupled to work efficiently
and accurately, as the configurational space that has already
been sampled needs to be analyzed on-the-fly to inform on
how to proceed with further sampling. Furthermore, many
advanced sampling algorithms for biomolecular simulations
require flexible and scalable support for multiple simulations.
As no final solution yet exists on the best strategy for adaptive
sampling (and different physical systems may require a com-
bination of strategies), there is a need to allow combination of
different MD engines with different analysis tools, and can be
easily extended or modified by end-users to build their own
workflows, both for development of new strategies, and for
applications to the study of complex biomolecular systems.
ExTASY is designed and implemented to provide a signif-
icant step in this direction. ExTASY allows to simulate many
parallel MD trajectories (by means of standard MD engines),
to extract long timescale information from the trajectories (by
means of different dimensionality reduction methods), and to
use the information extracted from the data for adaptively
improving sampling. ExTASY has been utilized by different
MD engines and analysis algorithms, with only pre-defined
and localized changes.
In Section III, we formally identified the functional, per-
formance and usability requirements to support the coupling
of MD simulations with advanced sampling algorithms. We
then presented the design and implementation of ExTASY,
an extensible, portable and scalable Python framework for
building advanced sampling workflow applications to achieve
these requirements. After establishing accurate estimates of
the overhead of using ExTASY, Section V consisted of experi-
ments designed to validate the design objectives; we performed
experiments that characterized ExTASY along traditional scal-
ing metrics, but also investigated ExTASY beyond single weak
and strong scaling performance. With the exception of some
machine specific reasons,ExTASY displayed linear scaling for
both strong and weak scaling tests on various machines up to
O(1000) simulation instances on up to O(1000) nodes for both
DM-d-MD and CoCo-MD workflows.
In order to keep the footprint of new software small,
ExTASY builds upon well-defined and understood abstractions
and their efficient and interoperable implementation (Ensemble
Toolkit, RADICAL-Pilot). This provides double duty: The
core functionality of ExTASY can be provided by simple
higher level extensions of complex system software, while
allowing it to build upon the performance and optimization
of the underlying system software layers. This also allows
ExTASY to employ good systems engineering practice: well-
defined and good base performance, while being amenable
to platform-specific optimizations (e.g. using ORTE on Blue
Waters [37]).
The design of ExTASY to reuse existing capabilities, for
extensibility to different MD codes and sampling algorithms
while providing well defined functionality and performance
are essential features to ensure the sustainability of ExTASY.
Compared to existing software tools and libraries for advanced
sampling, ExTASY provides a much more flexible approach
that is agnostic of individual tools and compute platforms, is
architected to enable efficient and scalable performance and
has a simple but general user interface. The ExTASY toolkit
is freely available from http://www.extasy-project.org.
The ExTASY toolkit has been used to deliver two hands-
on computational science training exercises and tutorials to
the bio-molecular simulations community with a focus on
advanced sampling. Participants were given the opportunity
to utilize HPC systems in real time for advanced sampling
problems of their own. Details of both events can be found
at http://extasy-project.org/events.html#epccmay2016. A link
to the lessons and experience from the first workshop can be
found at: https://goo.gl/nMSd27.
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